Reply to “Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma”
Year: 2026
Type: letter
Source: Neuro-Oncology
Authors: Michael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, Shrishtee Kandoi, Phuong Nguyen, Milan R Savani, Diana D Shi, Sachein Sharma, Satomi Hiya, Carolina Maldonado-Díaz, Kevin Clare, Raquel T Yokoda, Meenakshi Vij, Ema Mir, Yurika Nishikawa, Melissa Umphlett, Raymund L Yong, Joshua B Bederson, Thenzing J Silva-Hurtado, Steven Brem, Dolores Hambardzumyan, Matija Snuderl, Mariano S Viapiano, Kalil G Abdullah, Samuel K McBrayer, Kimmo J Hatanpaa, Jamie M Walker, Nadejda M Tsankova, Timothy E Richardson
Institutions: State University of New York, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Harvard University, University of Pittsburgh, SUNY Upstate Medical University, NYU Langone Health, Massachusetts General Hospital, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Caris Life Sciences (United States), Dana-Farber Brigham Cancer Center, Tisch Cancer Institute, New York University, University of Pennsylvania, The University of Texas Southwestern Medical Center, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7207725306